Tower Research Capital (TRC)’s ImageneBio, Inc. Common Stock IMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.05K Buy
+190
New +$3.05K ﹤0.01% 4560
2025
Q1
Sell
-303
Closed -$5.96K 5480
2024
Q4
$5.96K Buy
303
+147
+94% +$2.89K ﹤0.01% 4219
2024
Q3
$3.24K Sell
156
-1,522
-91% -$31.7K ﹤0.01% 4877
2024
Q2
$33.2K Buy
1,678
+934
+126% +$18.5K ﹤0.01% 3409
2024
Q1
$12.7K Buy
744
+328
+79% +$5.59K ﹤0.01% 3457
2023
Q4
$9.84K Buy
416
+107
+35% +$2.53K ﹤0.01% 4339
2023
Q3
$16.1K Buy
309
+233
+307% +$12.1K ﹤0.01% 3574
2023
Q2
$6.01K Sell
76
-221
-74% -$17.5K ﹤0.01% 4728
2023
Q1
$13K Sell
297
-863
-74% -$37.8K ﹤0.01% 3975
2022
Q4
$37K Buy
1,160
+840
+263% +$26.8K ﹤0.01% 2565
2022
Q3
$13K Buy
320
+56
+21% +$2.28K ﹤0.01% 4271
2022
Q2
$14K Buy
264
+114
+76% +$6.05K ﹤0.01% 4141
2022
Q1
$11K Buy
150
+4
+3% +$293 ﹤0.01% 4177
2021
Q4
$22K Buy
146
+84
+135% +$12.7K ﹤0.01% 3563
2021
Q3
$9K Sell
62
-40
-39% -$5.81K ﹤0.01% 4441
2021
Q2
$17K Buy
+102
New +$17K ﹤0.01% 4043